Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues
Biorestorative Therapies, Inc. (BRTX) had Profit Margin of -2239.25% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$0.40M |
|
$-8.98M |
|
$0.03M |
|
$0.37M |
|
$11.96M |
|
$-11.56M |
|
$2.58M |
|
$-8.98M |
|
$-8.98M |
|
$-8.98M |
|
$-8.98M |
|
$-8.98M |
|
$-8.98M |
|
$-11.56M |
|
$-11.37M |
|
7.76M |
|
7.76M |
|
$-1.16 |
|
$-1.16 |
|
| Balance Sheet Financials | |
$11.14M |
|
$0.36M |
|
$1.14M |
|
$12.28M |
|
$3.75M |
|
-- |
|
-- |
|
$3.75M |
|
$8.52M |
|
$7.91M |
|
$8.53M |
|
6.92M |
|
| Cash Flow Statement Financials | |
$-8.23M |
|
$0.51M |
|
$7.38M |
|
$0.88M |
|
$0.55M |
|
$-0.34M |
|
$2.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.97 |
|
-- |
|
-- |
|
-- |
|
-- |
|
93.00% |
|
-2881.59% |
|
-2881.59% |
|
-2834.45% |
|
-2239.25% |
|
|
Profit Margin |
-2239.25% |
$-8.34M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
2.13 |
|
171.49 |
|
-105.42% |
|
-113.56% |
|
-73.12% |
|
-105.25% |
|
$1.23 |
|
$-1.07 |
|
$-1.06 |
|